These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30215578)

  • 1. Rotavirus vaccine efficacy: current status and areas for improvement.
    Carvalho MF; Gill D
    Hum Vaccin Immunother; 2019; 15(6):1237-1250. PubMed ID: 30215578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Immunity and acute viral gastroenteritis.
    Rose MA
    Hum Vaccin Immunother; 2014; 10(7):2112-4. PubMed ID: 25424826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus: realising the potential of a promising vaccine.
    Nelson EA; Glass RI
    Lancet; 2010 Aug; 376(9741):568-70. PubMed ID: 20692032
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
    Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.
    Plosker GL
    Paediatr Drugs; 2012 Dec; 14(6):429-33. PubMed ID: 23013458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.
    Giaquinto C; Dominiak-Felden G; Van Damme P; Myint TT; Maldonado YA; Spoulou V; Mast TC; Staat MA
    Hum Vaccin; 2011 Jul; 7(7):734-48. PubMed ID: 21734466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.
    Plosker GL
    Drugs R D; 2012 Dec; 12(4):239-44. PubMed ID: 23017130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers.
    Lal M; Jarrahian C; Zhu C; Hosken NA; McClurkan CL; Koelle DM; Saxon E; Roehrig A; Zehrung D; Chen D
    Vaccine; 2016 May; 34(22):2483-9. PubMed ID: 27085171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
    Isanaka S; Langendorf C; McNeal MM; Meyer N; Plikaytis B; Garba S; Sayinzoga-Makombe N; Soumana I; Guindo O; Makarimi R; Scherrer MF; Adehossi E; Ciglenecki I; Grais RF
    PLoS Med; 2021 Jul; 18(7):e1003655. PubMed ID: 34214095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014.
    Karafillakis E; Hassounah S; Atchison C
    Vaccine; 2015 Apr; 33(18):2097-107. PubMed ID: 25795258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.
    Tsolenyanu E; Mwenda JM; Dagnra A; Leshem E; Godonou M; Nassoury I; Landoh D; Tate JE; Atakouma Y; Parashar UD
    Clin Infect Dis; 2016 May; 62 Suppl 2():S196-9. PubMed ID: 27059356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.
    Armah G; Pringle K; Enweronu-Laryea CC; Ansong D; Mwenda JM; Diamenu SK; Narh C; Lartey B; Binka F; Grytdal S; Patel M; Parashar U; Lopman B
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S200-7. PubMed ID: 27059357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013-2014.
    Pringle KD; Patzi M; Tate JE; Iniguez Rojas V; Patel M; Inchauste Jordan L; Montesano R; Zarate A; De Oliveira L; Parashar U
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S115-20. PubMed ID: 27059344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of rotavirus vaccines.
    Wang CM; Chen SC; Chen KT
    World J Pediatr; 2015 Nov; 11(4):300-8. PubMed ID: 26454434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
    Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
    Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.